共 193 条
[1]
Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30
[2]
Miller KD(2000)Molecular portraits of human breast tumours Nature 406 747-752
[3]
Jemal A(2013)Molecular characterization of basal-like and non-basal-like triple-negative breast cancer Oncologist 18 123-133
[4]
Perou CM(2011)Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies J Clin Invest 121 2750-2767
[5]
Sørlie T(2016)18F-FDG PET/CT for staging and restaging of breast cancer J Nucl Med 57 17S-26S
[6]
Eisen MB(2016)18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials Eur J Nucl Med Mol Imaging 43 983-993
[7]
van de Rijn M(2015)Correlation of primary tumor FDG uptake with clinicopathologic prognostic factors in invasive ductal carcinoma of the breast Nucl Med Mol Imaging 49 19-25
[8]
Jeffrey SS(2012)Prognostic impact of 18FDG-PET-CT findings in clinical stage III and IIB breast cancer J Natl Cancer Inst 19 1879-1887
[9]
Rees CA(2016)18F-FDG/PET may help to identify a subgroup of patients with T1-T2 breast cancer and 1–3 positive lymph nodes who are at a high risk of recurrence after mastectomy Cancer Res Treat 48 508-517
[10]
Prat A(2008)Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters Cancer 112 995-1000